VRS
CORT icon

Virginia Retirement Systems’s Corcept Therapeutics CORT Stock Holding History

Virginia Retirement Systems’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$396K Sell
11,374
-4,800
-30% -$377K ﹤0.01% 800
2025
Q3 		$1.34M Sell
16,174
-400
-2% -$28.9K 0.01% 505
2025
Q2 		$1.22M Sell
16,574
-100
-0.6% -$7.25K 0.01% 531
2025
Q1 		$1.9M Buy
+16,674
New +$1.01M 0.01% 381
2023
Q3 		$1.61M Sell
59,000
-5,200
-8% -$150K 0.02% 386
2023
Q2 		$1.43M Sell
64,200
-900
-1% -$20.7K 0.01% 443
2023
Q1 		$1.41M Buy
65,100
+16,600
+34% +$364K 0.01% 441
2022
Q4 		$985K Buy
48,500
+4,100
+9% +$103K 0.01% 611
2022
Q3 		$1.14M Buy
+44,400
New +$1.19M 0.01% 532
2022
Q1 		$1.37M Sell
60,700
-7,500
-11% -$160K 0.01% 539
2021
Q4 		$1.35K Sell
68,200
-1,100
-2% -$22.3K 0.01% 552
2021
Q3 		$1.36M Buy
69,300
+18,800
+37% +$393K 0.01% 529
2021
Q2 		$1.11M Buy
50,500
+2,200
+5% +$49K 0.01% 610
2021
Q1 		$1.15M Buy
48,300
+6,200
+15% +$166K 0.01% 604
2020
Q4 		$1.1M Sell
42,100
-7,600
-15% -$160K 0.01% 573
2020
Q3 		$865K Sell
49,700
-19,300
-28% -$308K 0.01% 582
2020
Q2 		$1.16M Sell
69,000
-11,500
-14% -$162K 0.01% 515
2020
Q1 		$957K Buy
80,500
+8,000
+11% +$99K 0.01% 572
2019
Q4 		$877K Sell
72,500
-20,000
-22% -$278K 0.01% 742
2019
Q3 		$1.31M Sell
92,500
-8,700
-9% -$107K 0.01% 580
2019
Q2 		$1.13M Sell
101,200
-19,700
-16% -$220K 0.01% 634
2019
Q1 		$1.42M Buy
120,900
+48,300
+67% +$600K 0.02% 536
2018
Q4 		$970K Buy
72,600
+58,800
+426% +$777K 0.01% 629
2018
Q3 		$193K Sell
13,800
-63,900
-82% -$893K ﹤0.01% 1020
2018
Q2 		$1.22M Sell
77,700
-6,500
-8% -$113K 0.02% 624
2018
Q1 		$1.39M Sell
84,200
-12,300
-13% -$228K 0.02% 555
2017
Q4 		$1.74M Sell
96,500
-12,000
-11% -$217K 0.02% 516
2017
Q3 		$2.09M Buy
108,500
+97,700
+905% +$1.46M 0.03% 486
2017
Q2 		$127K Buy
+10,800
New +$117K ﹤0.01% 1024

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virginia Retirement Systems's CORT Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Corcept Therapeutics (CORT) stake by 30% in Q4 2025, selling an estimated $377K and leaving 11,374 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Virginia Retirement Systems first reported a position in CORT in Q2 2017 and has held it in 29 quarters since. The position peaked at $2.09M in Q3 2017. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Virginia Retirement Systems held 11,374 shares of Corcept Therapeutics worth $396K as of Q4 2025.
  • Virginia Retirement Systems sold 4,800 Corcept Therapeutics shares in Q4 2025, an estimated $377K.
  • Corcept Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #800 holding.
  • Virginia Retirement Systems first reported a position in Corcept Therapeutics in Q2 2017 and has held it in 29 quarters since.
  • Virginia Retirement Systems's Corcept Therapeutics position peaked at $2.09M in Q3 2017.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.